These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 14290813)
21. [THE SEPARATION OF NUCLEIC ACID COMPONENTS WITH SEPHADEX]. HOHN T; POLLMANN W Z Naturforsch B; 1963 Nov; 18():919-22. PubMed ID: 14101866 [No Abstract] [Full Text] [Related]
22. Novel modified purine bases and nucleosides: new methodologies of synthesis and biological activity. Hocek M Nucleic Acids Symp Ser (Oxf); 2005; (49):29-30. PubMed ID: 17150617 [TBL] [Abstract][Full Text] [Related]
23. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS. BOOTH BA; SARTORELLI AC Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870 [No Abstract] [Full Text] [Related]
24. [STUDY OF SOME PHARMACODYNAMIC PROPERTIES OF NUCLEOSIDES AT THE LEVEL OF THE CARDIOVASCULAR SYSTEM]. EYRAUD H; AUROUSSEAU M J Physiol (Paris); 1964; 56():344-5. PubMed ID: 14219776 [No Abstract] [Full Text] [Related]
25. SYNTHESIS OF POTENTIAL ANTINEOPLASTIC AGENTS. XXXI. 9-ALKYL-9H-PURINES. TEMPLE C; KUSSNER CL; MONTGOMERY JA J Med Pharm Chem; 1962 Jul; 5():866-70. PubMed ID: 14056420 [No Abstract] [Full Text] [Related]
27. [DEMONSTRATION OF RESONANCES OF PIEZOELECTRIC ORIGIN IN PURINE, CYTOSINE AND VARIOUS NUCLEIC ACID NUCLEOSIDES]. MESSARD G; VASILESCU D C R Hebd Seances Acad Sci; 1964 Mar; 258():3373-6. PubMed ID: 14142561 [No Abstract] [Full Text] [Related]
28. Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines. Yoon JS; Jarhad DB; Kim G; Nayak A; Zhao LX; Yu J; Kim HR; Lee JY; Mulamoottil VA; Chandra G; Byun WS; Lee SK; Kim YC; Jeong LS Eur J Med Chem; 2018 Jul; 155():406-417. PubMed ID: 29906687 [TBL] [Abstract][Full Text] [Related]
29. STUDIES ON NUCLEOSIDES AND NUCLEOTIDES. VII. SYNTHESIS OF 2-AMINO-6-SUBSTITUTED-9-BETA-D-RIBOFURANOSYLPURINES. NAITO T; UENO K; ISHIKAWA F Chem Pharm Bull (Tokyo); 1964 Aug; 12():951-4. PubMed ID: 14220874 [No Abstract] [Full Text] [Related]
30. The correlation between the antitumor activities and chemical structures of thiocyanato derivatives of purines and their ribonucleosides. Saneyoshi M; Tokuzen R; Maeda M; Fukuoka F Chem Pharm Bull (Tokyo); 1968 Mar; 16(3):505-8. PubMed ID: 5677940 [No Abstract] [Full Text] [Related]
31. [SEPARATION AND DETERMINATION OF NUCLEOSIDES IN PHARMACEUTICAL PREPARATIONS]. CARDINI C; QUERCIA V; CALO A Boll Chim Farm; 1964 Nov; 103():815-24. PubMed ID: 14275919 [No Abstract] [Full Text] [Related]
32. Relation of structure of purine and pyrimidine nucleosides to antitumor activity. Goldin A; Wood HB; Engle RR Cancer Chemother Rep 2; 1968 Oct; 1(1):1-272. PubMed ID: 5743752 [No Abstract] [Full Text] [Related]
33. [ON MOBILITY OF PURINES AND PYRIMIDINE BASES AND THEIR DERIVATIVES DURING ELECTROPHORETIC SEPARATION]. KASATKIN IN; FEDOROV NA Lab Delo; 1964; 10():156-9. PubMed ID: 14141935 [No Abstract] [Full Text] [Related]
34. NUCLEOSIDES. IV. 1-(2-DEOXY-BETA-D-LYXOFURANOSYL)-5-IODOURACIL. HORWITZ JP; CHUA J; NOEL M; DAROOGE MA J Med Chem; 1964; 7():385-6. PubMed ID: 14204995 [No Abstract] [Full Text] [Related]
35. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues. Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780 [TBL] [Abstract][Full Text] [Related]